Article

Mapping progressive brain structural changes in early Alzheimer's disease and mild cognitive impairment.

Department of Neurology, David Geffen School of Medicine, UCLA, CA, United States.
Neuropsychologia (Impact Factor: 3.45). 02/2008; 46(6):1597-612. DOI: 10.1016/j.neuropsychologia.2007.10.026
Source: PubMed

ABSTRACT Alzheimer's disease (AD), the most common neurodegenerative disorder of the elderly, ranks third in health care cost after heart disease and cancer. Given the disproportionate aging of the population in all developed countries, the socio-economic impact of AD will continue to rise. Mild cognitive impairment (MCI), a transitional state between normal aging and dementia, carries a four- to sixfold increased risk of future diagnosis of dementia. As complete drug-induced reversal of AD symptoms seems unlikely, researchers are now focusing on the earliest stages of AD where a therapeutic intervention is likely to realize the greatest impact. Recently neuroimaging has received significant scientific consideration as a promising in vivo disease-tracking modality that can also provide potential surrogate biomarkers for therapeutic trials. While several volumetric techniques laid the foundation of the neuroimaging research in AD and MCI, more precise computational anatomy techniques have recently become available. This new technology detects and visualizes discrete changes in cortical and hippocampal integrity and tracks the spread of AD pathology throughout the living brain. Related methods can visualize regionally specific correlations between brain atrophy and important proxy measures of disease such as neuropsychological tests, age of onset or factors that may influence disease progression. We describe extensively validated cortical and hippocampal mapping techniques that are sensitive to clinically relevant changes even in the single individual, and can identify group differences in epidemiological studies or clinical treatment trials. We give an overview of some recent neuroimaging advances in AD and MCI and discuss strengths and weaknesses of the various analytic approaches.

0 Followers
 · 
68 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Memory tests able to differentiate encoding and retrieval processes from the memoranda storing ones should be used to differentiate patients in a very early phase of AD. In fact, individuals with mild cognitive impairment (MCI) can be characterized by two different memory profiles: a pure amnestic one (with poor learning and retrieval and poor improvement when encoding is assisted and retrieval is facilitated) and a dysexecutive one (with inefficient encoding and/or poor retrieval strategies and improvement with assisted encoding and retrieval). The amnestic profile characterizes subjects affected by medio-temporal atrophy typical of AD. In this study, a Grober-Buschke memory procedure was used to evaluate normal controls and MCI patients with different cognitive profiles: pure amnestic (aMCIsd), amnestic plus other cognitive impairments (aMCImd) and non-amnestic (naMCI). An index of sensitivity of cueing (ISC) measured the advantage passing from free to cued recall. Results showed that both strategic and consolidation abilities were impaired in the aMCIsd and aMCImd groups and were preserved in the naMCI group. aMCImd, however, compensated the memory deficit with assisted encoding and retrieval, but aMCIsd performed very poorly. When MCI subjects were defined according to the ISC value, subjects with poor ISC were primarily in the aMCIsd group and, to a lesser extent, in the aMCImd group and the naMCI group. Finally, patients with a poor ISC showed cerebral atrophy documented in the precocious phase of AD and the retrosplenial cerebral areas seemed to be the most useful areas for identifying patients in the early phase of AD.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Alzheimer’s disease (AD) is an amyloid-facilitated tauopathy (Braak et al., 2000) whose origin and subsequent advance within the brain is well characterized: the disease begins in the mesial temporal lobe, an event accompanied by the accumulation of misfolded β-amyloid and tau proteins, and thence progresses along fiber pathways. Histopathological evidence of this highly stereotyped progression has come to be known as the Braak model (Braak and Braak, 1996): neurofibrillary tau tangles are first found in entorhinal cortex and hippocampus (stages I–II), then spread into the amygdala and basolateral temporal lobe (stages III–IV), followed by isocortical association areas (stages V–VI). Morphological changes accompanying this pathological progression are clearly visible on MRI, especially from cross-sectional and longitudinal morphometric mapping (Fischl et al., 2002, Klauschen et al., 2009, Smith et al., 2004 and Wu et al., 2007). Longitudinal studies (Apostolova and Thompson, 2008, Apostolova et al., 2007, Thompson et al., 2003 and Whitwell et al., 2007) confirm that progression follows vulnerable fiber pathways rather than spatial proximity (Englund et al., 1988, Kuczynski et al., 2010 and Villain et al., 2008), closely mirroring Braak pathological stages (Whitwell et al., 2007).
    Cell Reports 01/2015; 46(3). DOI:10.1016/j.celrep.2014.12.034 · 7.21 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective: to evaluate the risk of dysphagia and its relationship with the stage of Alzheimer's Disease, as well as the relationship between the risk of dysphagia and nutritional status and caloric intake in elderly people with Alzheimer's disease. Methods: the sample consisted of 30 subjects of both genders with probable Alzheimer's disease. The stage of the disease, nutritional status, energy intake, and risk of dysphagia were assessed. Results: it was found that increased risk of dysphagia is associated with the advance in the stages of Alzheimer's disease and that even patients in the early stages of disease have a slight risk of developing dysphagia. No association was found between nutritional status and the risk of dysphagia. High levels of inadequate intake of micronutrients were also verified in the patients. Conclusion: an association between dysphagia and the development of Alzheimer's disease was found. The results indicate the need to monitor the presence of dysphagia and the micronutrient intake in patients with Alzheimer's disease.
    Revista Latino-Americana de Enfermagem 03/2014; 22(2):317-324. DOI:10.1590/0104-1169.3252.2418 · 0.54 Impact Factor

Full-text (2 Sources)

Download
41 Downloads
Available from
May 23, 2014